Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Capitalzodiac Unveils "Geo-Matrix" – A Revolutionary Analytical Framework for the Global Strategic Minerals Sector
-
NEURONES: Declaration of transactions on treasury shares (March 23 to 27, 2026)
-
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
-
DriverAI Mileage Tracking App Review: Smart Automation That Actually Works
-
Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026
-
Appili Therapeutics to Exhibit at World Vaccine Congress Washington
-
BLUENERGIES ANNOUNCES TRADING ON OTCQX BEST MARKET UNDER THE TRADING SYMBOL "BLUGF"
-
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
-
Nicus to Spotlight AI-Driven IT Financial Management at 2026 ITFMA Annual Conference
-
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
-
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
-
Bayport Management Ltd Standalone Financial Statements year ended December 2025
-
Advocating for Awareness: RHA Celebrates Developmental Disabilities Awareness Month
-
Sasol Financing USA LLC Announces the Commencement of Cash Tender Offers for Outstanding Debt Securities and New Senior Notes Offering
-
New Analyses: EPA Consistently Fails to Warn Public of Pesticide Cancer Risks
-
Sound Seal Adds Two Regional Sales Managers to Support U.S. Growth
-
KLDC Expands Multi-Phase Gold System and Secures OJEP Funding
-
Bayport Management Ltd Group Audited Financial Statements year ended December 2025
-
The Operation of RedotPay Secures ISO/IEC 27001 Certification
-
Argyle announces integration with Vesta to embed direct-source verifications within the loan origination system
-
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
-
Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent
-
urban-gro, Inc. Positions for Entry into Multi-Billion-Dollar T20 Cricket Market with LPL Season Six Player Auction on May 15, 2026 via IPG Platform
-
Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan
-
Benzinga and Rapunzl Establish Data Relationship to Bring Real-World Market Perspectives into Financial Education
-
Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
-
Women in HVACR opens call for speakers for 2026 annual conference
-
PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024
-
Hercules Metals Intersects 670 m of 0.45% Copper, 4 g/t Ag and 95 ppm Mo, including 213 m of 0.67% Copper, 10 g/t Ag, 128 ppm Mo at the Leviathan Porphyry System in Idaho
-
Gladiator Receives Class 3 Exploration Permit for Whitehorse Copper Project
-
Delta-1 Gold Project Awarded $200,000 Funding Under the Ontario Junior Exploration Program
-
TempraMed Signs LOI for Distribution Agreement in Panama, Expanding Central American Exposure
-
Tiny Reports Q4 2025 and Full Year 2025 Results
-
Connect Biopharma Announces $20.2 Million Private Placement Financing
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Lithium Africa Corp. Completes the First Phase of the Acquisition of the Springbok Project
-
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
-
Intrepid Metals Announces Leadership Transition Following Strategic Validation and Positions Company for Next Phase of Growth
-
Apollo Reports Results of Annual General Meeting and Appointment of New Executive Chair and Lead Director
-
DENARIUS METALS ANNOUNCES POSITIVE PEA RESULTS FOR ITS 100%-OWNED ZANCUDO PROJECT IN COLOMBIA
-
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
-
Jay's Heating, Air & Plumbing launches Altitude Academy, investing in the future of skilled trades with state-of-the-art training facility
-
Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
-
Nearly 3 in 10 (29%) Gig Workers Risk Significant Penalties by Not Declaring Gig Income - Despite Regulations Requiring Gig Platforms to Report Workers’ Income to the CRA: H&R Block Canada Surve
-
49 new Nova LFS buses for the Greater Hamilton Area
-
Full Market Visibility Is Crucial for Winning Deals: What PE Firms Need to Know Now
-
Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease
-
Exchange Income Corporation Announces Renewal of Normal Course Issuer Bid for Common Shares
-
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
-
Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered
